The Latest Cardiac and Vascular News
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The […]
LONDON, July 11, 2023 (GLOBE NEWSWIRE) — PMcardio, a leading force in AI-powered diagnostics for cardiovascular diseases, announces expansion into 15 additional European markets with the launch of its newest version. After a successful initial launch in the United Kingdom, with over 25 000 registered users, PMcardio is now making its […]
HINGHAM, Mass., July 11, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced that Irene Bargellini, M.D., an interventional radiologist and Chair of the Diagnostic and Interventional Radiology Department at Candiolo Cancer Institute in […]
CAMPBELL, Calif., July 11, 2023 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, announces its support for rural healthcare by providing access to its innovative remote patient monitoring (RPM) solutions. With nearly half the world’s population living in rural and remote locations, access to modern healthcare can be challenging – often […]
SANTA CLARA, Calif., July 11, 2023 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 […]
SOUTHLAKE, Texas, July 11, 2023 /PRNewswire/ — Renibus Therapeutics, Inc., (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to RBT-1 for the reduction in risk of post-operative complications in patients undergoing cardiothoracic […]
Adona Medical’s Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference PR Newswire Innovative platform designed for more personalized, tailored management of heart failure patients LOS GATOS, Calif. , July 10, 2023 /PRNewswire/ — Adona Medical , a Shifamed portfolio company that aims to deliver advanced interatrial shunting and hemodynamic monitoring systems for […]
NEW YORK–(BUSINESS WIRE)–AccurKardia, a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance. AccurECG™ is a cloud-based, device-agnostic and fully automated electrocardiogram (ECG) interpretation software platform. The groundbreaking AccurECG™ software provides an array […]
DUBLIN–(BUSINESS WIRE)– FIRE1 today announced that the first U.S. patients have been successfully implanted with its FIRE1™ System for remote heart failure monitoring in an Early Feasibility Study. The study will assess FIRE1’s novel solution to improve outcomes for heart failure patients. The first patient was implanted at Austin Heart, Texas, where […]
EAST HANOVER, N.J., July 10, 2023 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin therapy1. […]
